Inventor · disambiguated record
Masaru Kanekiyo
Also filed as: KANEKIYO MASARU
28 granted patents·11 pending applications·138 citations·filing 2003–2024
95Inventor score
Files withUS HEALTH20THE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES6THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES4DEPT OF MEDICAL SCIENCES MINIS2GLAXOSMITHKLINE BIOLOGICALS SA2
Top patents by PatentIndex Score
39 records- 0196US10301377B2Middle east respiratory syndrome coronavirus immunogens, antibodies, and their useUS HEALTH·Filed 2016·Granted May 28, 2019·24 cites·23 claims
- 0294US10017543B2Prefusion RSV F proteins and their useUS HEALTH·Filed 2014·Granted Jul 10, 2018·26 cites·58 claims
- 0393US11793871B2Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereofUS HEALTH·Filed 2022·Granted Oct 24, 2023·2 cites·18 claims
- 0493US10961283B2Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigensUS HEALTH·Filed 2017·Granted Mar 30, 2021·11 cites·34 claims
- 0593US10960070B2Prefusion coronavirus spike proteins and their useUS HEALTH·Filed 2017·Granted Mar 30, 2021·25 cites·23 claims
- 0692US11939356B2Self-assembling insect ferritin nanoparticlesUS HEALTH·Filed 2021·Granted Mar 26, 2024·2 cites·19 claims
- 0790US11338033B2Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereofTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2017·Granted May 24, 2022·5 cites·15 claims
- 0890US10137190B2Nucleic acid molecules encoding ferritin-hemagglutinin fusion proteinsUS HEALTH·Filed 2016·Granted Nov 27, 2018·10 cites·17 claims
- 0989US12268737B2Stabilized influenza hemagglutinin stem region trimers and uses thereofUS HEALTH·Filed 2024·Granted Apr 8, 2025·0 cites·21 claims
- 1089US2025368690A1Prefusion rsv f proteins and their useTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2024·Application pending·0 cites
- 1187US11981707B2Prefusion RSV F proteins and their useUS HEALTH·Filed 2023·Granted May 14, 2024·0 cites·25 claims
- 1287US11130785B2Prefusion RSV F proteins and their useUS HEALTH·Filed 2018·Granted Sep 28, 2021·2 cites·24 claims
- 1387US10744199B2Epstein-Barr virus vaccinesTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2014·Granted Aug 18, 2020·4 cites·9 claims
- 1487US10363301B2Stabilized influenza hemagglutinin stem region trimers and uses thereofUS HEALTH·Filed 2015·Granted Jul 30, 2019·5 cites·18 claims
- 1585US11147867B2Stabilized influenza hemagglutinin stem region trimers and uses thereofTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2019·Granted Oct 19, 2021·1 cites·21 claims
- 1685US7638133B2Recombinant BCG vaccineDEPT OF MEDICAL SCIENCES MINIS·Filed 2003·Granted Dec 29, 2009·20 cites·2 claims
- 1784US11969466B2Stabilized influenza hemagglutinin stem region trimers and uses thereofUS HEALTH·Filed 2023·Granted Apr 30, 2024·0 cites·20 claims
- 1882US2024408195A1Epstein-barr virus vaccinesTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2024·Application pending·0 cites
- 1980US12410240B2Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infectionUS HEALTH·Filed 2024·Granted Sep 9, 2025·0 cites·16 claims
- 2078US11679151B2Stabilized influenza hemagglutinin stem region trimers and uses thereofTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2021·Granted Jun 20, 2023·0 cites·21 claims
- 2175US11926656B2Antibodies and methods for the diagnosis and treatment of Epstein Barr Virus infectionUS HEALTH·Filed 2021·Granted Mar 12, 2024·0 cites·20 claims
- 2275US11191727B2Multivalent nanoparticle-based vaccinesTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2015·Granted Dec 7, 2021·1 cites·3 claims
- 2375US2022002351A1Prefusion rsv f proteins and their useTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2021·Application pending·0 cites
- 2475US2024390706A1Antibodies and methods for the diagnosis, prevention, and treatment of epstein barr virus infectionUS HEALTH·Filed 2024·Application pending·0 cites
- 2574US2024226012A1Novel multivalent nanoparticle-based vaccinesTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2024·Application pending·0 cites
- 2672US11938221B2Multivalent nanoparticle-based vaccinesUS HEALTH·Filed 2021·Granted Mar 26, 2024·0 cites·8 claims
- 2770US12005115B2Epstein-barr virus vaccinesTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2020·Granted Jun 11, 2024·0 cites·1 claims
- 2867US12084489B2Antibodies and methods for the diagnosis, prevention, and treatment of Epstein Barr virus infectionUS HEALTH·Filed 2019·Granted Sep 10, 2024·0 cites·32 claims
- 2966US11964010B2Prefusion coronavirus spike proteins and their useUS HEALTH·Filed 2021·Granted Apr 23, 2024·0 cites·15 claims
- 3065US2025127877A1Novel immunogens for influenza virus vaccinesUNIV WASHINGTON·Filed 2023·Application pending·0 cites
- 3163US2024181038A1Immunogenic compositionsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 3260US10759846B2Middle east respiratory syndrome coronavirus immunogens, antibodies, and their useUS HEALTH·Filed 2019·Granted Sep 1, 2020·0 cites·26 claims
- 3357US7670610B2Recombinant BCG vaccineDEPT OF MEDICAL SCIENCES MINIS·Filed 2008·Granted Mar 2, 2010·0 cites·2 claims
- 3457US2014072958A1Novel influenza hemagglutinin protein-based vaccinesUS HEALTH·Filed 2013·Application pending·0 cites
- 3557US2023090779A1Engineered influenza neuraminidase antigensUNIV WASHINGTON·Filed 2021·Application pending·0 cites
- 3655US11236151B2Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infectionTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2018·Granted Feb 1, 2022·0 cites·16 claims
- 3755US2024165224A1Immunogenic compositionsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 3850US12433943B2Nanoparticle-based influenza virus vaccines and uses thereofTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2020·Granted Oct 7, 2025·0 cites·30 claims
- 3942US2014348865A1Immunogens based on an hiv-1 v1v2 site-of-vulnerabilityUS OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SER·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Masaru Kanekiyo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →